Skip to main content

Determination of serum insulin-like growth factor-I reference values for the automated chemiluminescent Liaison assay. Clinical utility in the follow-up of patients with treated acromegaly.

Massart C, Poirier JY

Publication: Clin Chim Acta (2011) • Vol 412 • Page 398-9PMID: 21059350View on PubMed

Purpose

The purpose of this paper was to determine the effects of storage, age, gender, and assay on insulin like growth factor-I (IGF-I) levels in serum from healthy donors and patients with acromegaly.

Conclusion

The reference range of serum IGF-I concentrations in healthy individuals decreased with age. Median values were lower in men than in women, with the exception of the 61-75 year age range. While lower levels of IGF-I were measured by the Liaison assay (chemiluminescent) compared with the Immunotech assay (immunoradiometric), results for patients with acromegaly were well correlated between the two assay types (r=0.899). Storage of serum for 5 years at -80 degrees C had no effect on IGF-I levels.

Studies (2)

Purpose

The purpose of this study was to determine the effects of age, gender, and assay on serum IGF-I levels in healthy donors and patients with acromegaly.

Summary of Findings

The reference range of serum IGF-I concentrations in healthy individuals decreased with age. Median values were lower in men than in women, with the exception of the 61-75 year age range. Notably, only half as many subjects were included in this age range. While lower levels of IGF-I were measured by the Liaison assay compared with the Immunotech assay, results for patients with acromegaly were well correlated between the two assay types (r=0.899). Further, 62.1% and 65.7% of serum specimens from patients with acromegaly had levels of IGF-I within normal ranges as determined by the Liaison and Immunotech assays, respectively. The authors note that the reference values given by the Liaison manufacturer appear to be slightly inaccurate.

  • Biospecimens

    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    Other diagnoses
  • Platforms

    ProteinRadioimmunoassay
    ProteinChemiluminescence
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Acromegaly
    PreaquisitionPatient age
    29-40 y
    41-50 y
    51-60 y
    61-75 y
    PreaquisitionPatient gender
    Female
    Male
    Radioimmunoassay SpecificTechnology platform
    Chemiluminescence